FRM9910 - NFIF - Introduction to Pharmacoepidemiology

Course content

Using current examples and with the participation of active researchers in pharmacoepidemiology, this course addresses a range of study designs and analytic techniques for observational studies on the utilization, safety, and effectiveness of pharmaceuticals. Students will develop an understanding of how to plan, implement, analyse, and criticize pharmacoepidemiological studies. Original research will be presented by principal investigators, followed by intensive discussions on design options, analytic strategies, and sensitivity analyses of confounding and misclassification bias. Lectures will provide methodological background and will cover applied issues typically encountered in pharmacoepidemiology.

Learning outcome

After completing the course the student should be able:

  • to plan and implement pharmacoepidemiological studies
  • to analyse data from pharmacoepidemiological studies
  • to criticize pharmacoepidemiological studies

 Admission

The final  registration deadline is 10 October 2015. Registration is done by filling out an online application form.

PhD candidates who are admitted to other education institutions than UiO must at the same time apply for visiting status. They must submit the same documentation as regular visiting status applicants, but the application and documentation (Official documentation of your admission to a PhD programme and confirmation from your supervisor/administration that the course/courses you wish to follow will be included as a part of the training component in your Phd programme) is to be sent by e-mail to The School of Pharmacy, halvor.aandal@farmasi.uio.no and not to the Faculty point of contact. Applicants must be able to present original documentation on request.

If the number of applicants exceeds the number of places available, PhD students who are members of the Norwegian School of Pharmacy and the Norwegian Research School in General Practice will have priority.

Published June 2, 2016 1:04 PM - Last modified Feb. 7, 2018 5:55 PM